Search Options Stock News and Analysis from Schaeffer's

https://www.schaeffersresearch.com/content/news/2024/12/23/2-sleep-apnea-stocks-in-focus-today

12/23/2024 10:51 AM

Eli Lilly and Co (NYSE:LLY) is in focus today, after the U.S. Food & Drug Administration (FDA) approved its weight-loss drug, Zepbound, to treat obstructive sleep apnea in adults with obesity -- the f...

Novo Nordisk Stock Eyes Worst Day, Week on Record

https://www.schaeffersresearch.com/content/news/2024/12/20/novo-nordisk-stock-eyes-worst-day-week-on-record

12/20/2024 10:29 AM

Novo Nordisk A/S (NYSE:NVO) stock is down 18.9% to trade at $82.25 at last check, after the pharmaceutical company's weight loss drug CagriSema missed expectations of a late-stage study. The populariz...

Hims and Hers Health Stock Testing Key Trendline

https://www.schaeffersresearch.com/content/news/2024/12/19/hims-and-hers-health-stock-testing-key-trendline

12/19/2024 3:39 PM

Hims & Hers Health Inc (NYSE:HIMS) stock is sitting out the broad market rally today, last seen down 8.4% to trade at $26.15. The personalized healthcare company -- a key player in the weight loss d...

Eli Lilly Touts Upbeat Weight-Loss Drug Results

https://www.schaeffersresearch.com/content/news/2024/12/04/eli-lilly-touts-upbeat-weight-loss-drug-results

12/4/2024 11:00 AM

The weight-loss drug market is about to get even more crowded. Eli Lilly & Co (NYSE:LLY) stock is up 2.2% at $830.80, after a news release reported the company's weight-loss drug Zepbound rivaled No...

Biotech Stock Reverses Gains Despite Obesity Pill Buzz

https://www.schaeffersresearch.com/content/news/2024/11/04/biotech-stock-reverses-gains-despite-obesity-pill-buzz

11/4/2024 10:42 AM

Viking Therapeutics Inc (NASDAQ:VKTX) stock is up 4.3% to trade at $74.13 at last glance, reversing course from earlier gains. The company earlier said its experimental obesity pill showed weigh...

PEOPLE ALSO SEARCH FOR